Who are Feldan Therapeutics's investors?

Feldan Therapeutics's investors include Asahi Kasei Corporate Venture Capital, Genesys Capital, Linearis Ventures, Fonds de solidarité FTQ, Zynext Ventures.

Feldan Therapeutics

5 known investors

Find your way into Feldan Therapeutics

Paths you didn't know you had: your email and LinkedIn already hold routes to the Feldan Therapeutics team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Feldan is a clinical-stage biotech company developing intracellular delivery technologies for therapeutic treatment of diseases. The company specializes in its Feldan Shuttle peptide-based technology to deliver antisense oligonucleotides and other therapeutics to cellular targets, with current programs targeting basal cell carcinoma and respiratory diseases.

Biotech Deep Tech Medical Devices

Founders & leadership

François-Thomas Michaud Board Member & Chief Executive OfficerFrançois-Thomas Michaud is CEO of Feldan Therapeutics, a clinical-stage biotech company developing peptide-based intracellular delivery technologies for therapeutic applications. He has more than 18 years of experience in biotech and life sciences, with expertise in partnership development and clinical program advancement.

Investors · 5

Asahi Kasei Corporate Venture Capitallisted by Asahi Kasei Corporate Venture CapitalMenlo Park · $200K – $5M

How we know: Asahi Kasei Corporate Venture Capital's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Genesys Capitallisted by Genesys CapitalToronto · $730K – $3.6M

How we know: Genesys Capital's portfolio page · funding news · finance.yahoo.com · open dataset · 5k.vc investor directory · Not right? Tell us

Linearis Ventureslisted by Linearis VenturesQuebec City

How we know: Linearis Ventures's portfolio page · funding news · press coverage · Not right? Tell us

Fonds de solidarité FTQreportedMontreal

How we know: funding news · finance.yahoo.com · Not right? Tell us

Zynext VenturesreportedPennington

How we know: funding news · press coverage · Not right? Tell us

Funding

SEC filings, press & company announcements

Undisclosed amountSeries BSep 2024
Fonds de solidarité FTQ (lead), Genesys Capital (lead)
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

2 people who came through Feldan Therapeutics went on to found or lead other companies.

Paul F. TruexDirectorFounded Lqttrx +2 David J. MazzoChairman of the Board of DirectorsFounded Lisata Therapeutics, Inc.

In the news

Feldan Therapeutics Receives Investment from Zynext Venturesfinsmes.com · Apr 2025

FELDAN THERAPEUTICS ACCELERATES GROWTH WITH STRATEGIC INVESTMENT FROM LINEARIS VENTURESfinance.yahoo.com · Feb 2025

Frequently asked questions

What does Feldan Therapeutics do?: Feldan is a clinical-stage biotech company developing intracellular delivery technologies for therapeutic treatment of diseases. The company specializes in its Feldan Shuttle peptide-based technology to deliver antisense oligonucleotides and other therapeutics to cellular targets, with current programs targeting basal cell carcinoma and respiratory diseases.
Who are Feldan Therapeutics's investors?: Feldan Therapeutics's investors include Asahi Kasei Corporate Venture Capital, Genesys Capital, Linearis Ventures, Fonds de solidarité FTQ, Zynext Ventures.